This inventor holds 4 USPTO granted patents and 2 published patent applications and 4 EPO patents. Top assignees: Ucb Biopharma Sprl, Boehringer Ingelheim International Gmbh, Novartis Ag. Active years: 2014-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Oxon, GB (2014)
- Abingdon, GB (2016)
- Didcot, GB (2016)
Company Filing History:
2 out of 139 
1 out of 1,562 
1 out of 3,977 
Years Active: 2014-2016
Title: The Innovations of Alexander Heifetz
Introduction
Alexander Heifetz is a notable inventor based in Abingdon, GB. He has made significant contributions to the field of pharmacology, holding a total of 4 patents. His work primarily focuses on developing compounds that can modulate various biological activities, which are crucial for treating a range of human ailments.
Latest Patents
Heifetz's latest patents include a series of substituted imidazo[1,2-a]pyrazines that serve as TNF activity modulators. These compounds are designed to be potent modulators of human TNFα activity, offering potential benefits in treating and preventing various conditions such as autoimmune and inflammatory disorders, neurological and neurodegenerative disorders, pain and nociceptive disorders, cardiovascular disorders, metabolic disorders, ocular disorders, and oncological disorders. Another significant patent involves compounds defined by a specific formula that possess valuable pharmacological activity. These compounds act as agonists of the 5-HT2C receptor, making them suitable for treating diseases influenced by the inhibition of this receptor, particularly metabolic and CNS-related disorders.
Career Highlights
Throughout his career, Heifetz has worked with prominent companies in the pharmaceutical industry, including UCB Biopharma and Boehringer Ingelheim International GmbH. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.
Collaborations
Heifetz has collaborated with notable colleagues such as Laura Gleave and Jonathan Bentley. These partnerships have likely enhanced his research and development efforts, leading to the successful creation of his patented compounds.
Conclusion
Alexander Heifetz's contributions to pharmacology through his innovative patents demonstrate his commitment to advancing medical science. His work continues to have a significant impact on the treatment of various human ailments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile